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Subcellular Dynamics of Somatostatin Receptor Subtype 1 in
the Rat Arcuate Nucleus: Receptor Localization and Synaptic
Connectivity Vary in Parallel with the Ultradian Rhythm of
Growth Hormone Secretion
Thomas Stroh,1,2Martine R. van Schouwenburg,1,2 Alain Beaudet,1,2 and Gloria S. Tannenbaum1,2,3,4
1Department of Neurology andNeurosurgery and 2Montreal Neurological Institute,McGill University,Montre´al, Que´becH3A 2B4, Canada, 3Department of
Pediatrics,McGill University,Montre´al, Que´becH3H 1P3, Canada, and 4Montreal Children’s Hospital Research Institute,Montre´al, Que´becH3H 1P3, Canada
Growth hormone (GH) secretion in male rats exhibits a 3.3 h ultradian rhythm generated by the reciprocal interaction of GH-releasing
hormone (GHRH) and somatostatin (SRIF). SRIF receptor subtypes sst1 and sst2 are highly expressed in GHRH neurons of the hypotha-
lamic arcuatenucleus (ARC).Wepreviouslydemonstratedanultradianoscillation inbindingof SRIFanalogs to theARC in relation toGH
peaks and troughs. Here we tested the hypothesis that these ultradian changes in SRIF binding are due to differential plasmamembrane
targetingof sst1 receptors inARCneuronsusing immunocytochemistry andelectronmicroscopy.We found that 87%of sst1-positiveARC
neurons also synthesized GHRH. Subcellularly, 80% of sst1 receptors were located intracellularly and 20% at the plasma membrane
regardless of GH status. However, whereas 30% of the cell-surface sst1 receptors were located perisynaptically or subsynaptically follow-
ing exposure to highGH secretion, this fractionwas increased to 42% following a GH trough period ( p 0.05). Furthermore, the relative
abundance of symmetric and asymmetric synapses on sst1-positive dendrites also varied significantly, depending on the GH cycle, from
approximately equal numbers following GH troughs to 70:30 in favor of symmetric, i.e., inhibitory, inputs after GH peaks ( p 0.02).
These findings suggest that postsynaptic localization of sst1 receptors and synaptic connectivity in theARCundergo pronounced remod-
eling in parallel with the GH rhythm. Such synaptic plasticity may be an important mechanism by which sst1 mediates SRIF’s cyclical
effects on ARC GHRH neurons to generate the ultradian rhythm of GH secretion.
Introduction
The secretion of growth hormone (GH) in male rodents exhibits
an endogenous ultradian rhythm with major bursts of GH secre-
tion occurring at regular 3.3 h intervals followed by trough peri-
ods of very low or undetectable basal plasma GH levels (Tannen-
baum and Martin, 1976). This rhythm is generated through the
interaction of two hypothalamic neuropeptides, GH-releasing
hormone (GHRH) and somatostatin (SRIF) in the hypophysis
and the hypothalamic arcuate nucleus (ARC) (Tannenbaum and
Epelbaum, 1999). In the male rat, these two neurohormones are
released in reciprocal 3–4 h cycles from the median eminence
into the hypophyseal portal circulation to act upon somatotropes
(Tannenbaum and Ling, 1984; Plotsky and Vale, 1985). Further-
more, we have postulated that SRIF is also released into the hy-
pothalamus with a 3.3 h periodicity (Wagner et al., 1998).
SRIF acts via a family of G-protein-coupled receptors
(GPCRs), sst1–sst5, which are differentially distributed through-
out theCNS (Csaba andDournaud, 2001;Olias et al., 2004). ARC
GHRHneurons express high levels of sst1 and sst2A mRNA (Tan-
nenbaum et al., 1998). Both receptor proteins are present in the
ARC,whereas other SRIF receptor subtypes are of low abundance
in this area (Hervieu and Emson, 1998; Stroh et al., 2006; Kumar,
2007) (but see also Helboe et al., 1998), consistent with the in-
volvement of sst1 and sst2 in the hypothalamic regulation of GH
secretion (Guo et al., 1996; Zheng et al., 1997; Zhang et al., 1999;
Lanneau et al., 2000).
In parallel with the ultradian GH secretion cycle, we found
that binding of radiolabeled, non-receptor subtype-selective
SRIF analogs to the ARC also oscillates in an ultradian manner;
thus, SRIF binding is highest during peaks in GH secretion and
lowest during GH troughs (Tannenbaum et al., 1993). This may
be due to differential plasma membrane targeting and cell-
surfacemaintenance of SRIF receptors. Indeed, the sst2A receptor
subtype rapidly internalizes in response to endogenous SRIF and
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exogenously applied agonists in neurons in which it previously
localized to the somatodendritic plasma membrane (Dournaud
et al., 1998; Csaba et al., 2001; Csaba et al., 2007). However, little
is known about mobilization and regulation of sst1 in hypotha-
lamic neurons in vivo.
In the present study, we hypothesized that the increase in SRIF
binding to the ARC during peaks in GH secretion may be due, at
least in part, to an increase in sst1 receptors at the cell surface of
GHRH neurons. Moreover, mounting evidence indicates that
ARC neurons may respond to changing physiological status of
the organism with changes in synaptic connectivity (Parducz et
al., 2003). Therefore, we further hypothesized that changes in
SRIF receptor targeting in the ARCmay be accompanied by vari-
ations in the synaptic connectivity of the nucleus. To test these
hypotheses, we examined, by electron microscopic immunohis-
tochemistry, the cellular and subcellular localization of sst1 re-
ceptors in the ARCofmale rats at times associatedwith peaks and
troughs of the GH secretion cycle and studied the synaptic con-
tacts of sst1-positive ARC neurons at the same time points.
Materials andMethods
Animals and experimental procedures.Adultmale SpragueDawley rats (200–
250 g; Charles River Canada) were individually housed in an isolated room
under a 12 h light, 12 h dark cycle (lights on: 6:00 A.M.) at 22 1°C and
constant air humidity. Purina rat chow (Ralston Purina) and tapwater were
available ad libitum. Chronic intravenous cannulae were implanted in the
external jugular veinunder sodiumpentobarbital anesthesia (50mg/kg, i.p.)
using a previously described technique (Tannenbaum and Martin, 1976).
After surgery, the rats were directly placed in isolation test chambers with
food andwater available ad libitum until bodyweight returned to preopera-
tive levels (usually within 5–7 d; n 6 animals).
On the day of the experiment, blood samples were withdrawn every 15
min fromunanesthetized, free-moving rats starting at 9:00 A.M. until either
11:00 A.M. or 1:00 P.M., when they were anesthetized with an intravenous
injection of sodium pentobarbital (35mg/kg). The times of 11:00 A.M. and
1:00 P.M. were chosen because we previously established that they corre-
spond to typical peak and trough periods of GH secretion, respectively, in
male rats maintained under the above photoperiodic conditions (Tannen-
baum and Martin, 1976; Tannenbaum and Ling, 1984). One animal each
was fixed for electronmicroscopy by transaortic perfusion (details below) at
either 11:00 A.M. or 1:00 P.M. so that in each experiment a pair of animals
fixed at these times was compared with each other. All blood samples were
immediately centrifuged, and theplasmawas separated and stored at20°C
for subsequentGHassay.Toavoidhemodynamicdisturbance, the redblood
cells were resuspended in normal saline and returned to the animal after
removal of the next blood sample.
Additional rats from the same source were housed under the same
conditions but not cannulated. They were fixed in themorning (between
9:00 and 10:00 A.M.) by perfusion with 4% paraformaldehyde (PFA) in
0.1 M phosphate buffer (PB) for immunohistochemical detection of sst1
and vesicular neurotransmitter transporters and for colocalization stud-
ies of sst1 with the vesicular transmitter transporters (n  3) or GHRH
(n  3) by immunofluorescence. No blood samples were withdrawn
from these animals. All animal procedures were performed in compli-
ance with the guidelines of the Canadian Coun-
cil on Animal Care and the McGill University
Animal Care Committee.
GH assay. Plasma GH concentrations were
measured in duplicate by double-antibody RIA
using materials supplied by the National Insti-
tute of Diabetes and Digestive and Kidney Dis-
eases Hormone Distribution Program. The av-
eraged plasma GH values are reported in terms
of the rat reference preparation (rGH RP-2).
The standard curve was linear between 0.62 and
160.0 ng/ml; the least detectable concentration
of plasma GH under the conditions used was
1.2 ng/ml. All samples with values of 160.0
ng/ml were reassayed at dilutions ranging from 1:2 to 1:10. The intra-
assay and interassay coefficients of variation were 7.7% and 10.7% re-
spectively, for duplicate samples of pooled plasma containing a mean
concentration of 60.7 ng/ml.
Double immunofluorescence. Adult male Sprague Dawley rats (200–
250 g) were anesthetized with ketamine/xylazine (80/10 mg/kg, i.p.) and
perfused transaortically with a freshly prepared solution of 4%PFA in 0.1
M PB, pH 7.4. Brains were rapidly removed, cryoprotected overnight at
4°C in 0.1 M PB containing 30% sucrose, and frozen for 1 min in isopen-
tane at40°C.
Coronal sections (30 m thick) were cut on a freezing microtome
throughout the rostrocaudal extent of the hypothalamus from the preoptic
area to the mammillary region and collected in 0.1 M PB. For immunofluo-
rescent double labeling of sst1 with vesicular neurotransmitter receptors,
sections were washed twice with 0.1 M Trizma base-buffered saline (TBS),
pH7.4, andpreincubated for30minat roomtemperature (RT) inablocking
solution containing 3% normal goat serum (NGS) in TBS. Subsequently,
they were incubated overnight at 4°C in a mixture of rabbit anti-sst1 and
eitherguineapiganti-vesicularglutamate transporter subtype2(VGluT2)or
mouse anti-vesicular GABA transporter protein (VGAT) appropriately di-
luted inTBScontaining0.05%TritonX-100and0.5%NGS(for sources and
dilutions, seeTable 1). Following rinsingwithTBS, boundprimary antibod-
ies were visualized by incubation in a mixture of Alexa 594 goat anti-rabbit
IgG, detecting the anti-sst1, and either Alexa 488 goat anti-guinea pig IgG or
Alexa 488 goat anti-mouse IgG for the detection of anti-VGluT2 or VGAT,
respectively (all diluted 1:800 in TBS, respectively; all purchased from In-
vitrogen). After final rinsing the sectionsweremountedonto chrome-alum-
coated slides using Aquapolymount (Polysciences). For GHRH/sst1 double
labeling (for antibody provenance and dilutions, see Table 1), a sequential
staining procedurewas adopted andNGSwas replacedwith normal donkey
serum in the immunostainingprotocol. Briefly, sectionswere first incubated
overnight at 4°C with sheep anti-GHRH. The following day, they were
rinsed, incubated for 45minatRTwithCy2donkey anti-sheep IgG(Jackson
ImmunoResearch) diluted 1:200 in TBS and subsequently incubated over-
night at 4°Cwith rabbit anti-sst1. The following day, they were rinsed, incu-
bated for 45min at RTwith Alexa 594 donkey anti-rabbit IgG (Invitrogen),
rinsed again, and mounted onto object slides using Aquapolymount. Two-
color confocal z-stacks were acquired on a Zeiss LSM 510 in channel mode
(Zeiss Canada). Three-dimensional processingwas performed usingVoloc-
ity release 4.0 (Improvision). The resulting images were adjusted for bright-
ness andcontrastusingPhotoshopCS2, and final compositeswere created in
MS Powerpoint 2003.
Stereological analysis of GHRH/sst1 double-labeled cell populations in the
ARC. For unbiased estimates of the GHRH- and sst1-positive cell popu-
lations and the proportion of double-positive cells, sections were ana-
lyzed by widefield fluorescence microscopy on a Nikon Eclipse E800
microscope (Nikon Instruments) equipped with an x/y/z-motorized
stage, a color CCD camera (Optronics,Microfire S99808), and appropri-
ate filter sets for Cy2 (excitation: bandpass 480/40 nm; dichroic mirror:
long-pass 505 nm; emission: bandpass 535/50 nm) and Alexa 594 (exci-
tation: bandpass 560/55 nm; dichroic mirror: long-pass 595 nm; emis-
sion: 645/75 nm).
GHRH- and sst1-positive neurons were mapped and counted using
theOptical Fractionator probe of StereoInvestigator (version 8.0,Micro-
BrightField) for systematic random sampling. Images were acquired and
Table 1. Primary antibodies and their dilutions in various applications
Primary antibody (source)
Dilutions
Immunohistochemistry Immunofluorescence Immuno-EM
Rabbit anti-sst1 custom (Stroh et al., 2006) 1:500 1:100 1:100
Sheep anti-GHRH custom (Tannenbaum et
al., 1990) 1:1000
Guinea pig anti-VGluT2 (Millipore Bioscience
Research Reagents) 1:5000 1:5000
Mouse anti-VGAT (Synaptic Systems) 1:500 1:200
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counts were performed using a 100 oil-
immersion objective (numerical aperture 1.4).
Counts were made through levels separated by
180 m throughout the rostrocaudal extent of
the ARC from three individual brains. On each
section, the outline of the ARC on both sides of
the third ventricle was drawn to define two re-
gions of interest (ROIs) per section, which were
both analyzed. For the first series of sections,
counts were performed using a counting frame
size of 25  25 m and a variable grid size to
yield five counting frames per ROI. Based on
the results from this pilot study, the final count-
ing frame size was adapted to 50 50 m, and
the grid size was fixed at 170 90m through-
out the analysis, which yielded 5–10 sampling
sites per ROI and assured a suitable sample size.
The average mounted section thickness ranged
from 16 to 26 m across section series, and di-
sector depth ranged from 14 to 24 m. Cells
were counted as their top came into focus be-
neath the top of the disector. The precision of
the population estimates was verified using
Gundersen’s coefficient of error (CE, m  1)
(Gundersen et al., 1999). The CEs obtained
from three brains ranged from 0.06 to 0.07 for
the total number of sst1-positive cells, from0.05
to 0.06 for the total number of GHRH-positive
neurons and from 0.06 to 0.08 for sst1/GHRH
dually positive cells. Means and SEs were calcu-
lated using Graph Pad Prism 4.03 (GraphPad
Software).
Electron microscopy. Sections were processed
for electron microscopic immunostaining us-
ing a preembedding procedure as described
previously (Dournaud et al., 1998; Boudin et
al., 2000; Stroh et al., 2006). Adultmale Sprague
Dawley rats (250–325 g)were anesthetizedwith
sodium pentobarbital (35 mg/kg, i.v.) and per-
fused transaortically with 50 ml of heparinized
saline (10 U/ml in 0.9% NaCl) followed by 50
ml of a mixture of 3.75% acrolein and 2% PFA
in 0.1 M PB, and then by 300 ml of 2% PFA in 0.1 M PB, pH 7.4. Brains
were rapidly removed from the skull and postfixed for 30 min at 4°C in
the 2% PFA solution. Sections (50 m thick) of the mediobasal hypo-
thalamuswere cut on a vibratome, collected in 0.1 MPB, and incubated in
a solution of 1% sodium borohydride in PB for 30 min to neutralize free
aldehyde groups. Following extensive rinsing with PB, they were cryo-
protected for 30 min by immersion in a mixture of 25% sucrose and 3%
glycerol in 0.1 M PB, rapidly frozen in isopentane at60°C, briefly trans-
ferred to liquid nitrogen, and thawed in 0.1 M PB at room temperature.
Sections thus permeabilized by freeze-thaw treatment were preincubated
for 30min in 0.1 M TBS, pH 7.4, containing 3%NGS and then incubated
overnight at 4°C in rabbit sst1 N-terminal antiserumdiluted 1:100 in TBS
containing 0.5% NGS. After rinsing in 0.01 M PBS, sections were incu-
bated for 2 h at RT in a 1:50 dilution of ultrasmall colloidal gold-
conjugated goat anti-rabbit Ig (Aurion) in PBS containing 0.2% gelatin
and 0.8%BSA. After several washes in PBS, sectionswere fixed for 10min
in 2% glutaraldehyde in PBS, washed in PBS, and rinsed twice in 0.2 M
citrate buffer, pH 7.4. Immunogold particles were amplified through
silver intensification by incubating the sections for 8minwith IntenSEM
silver solution (GE Healthcare). The reaction was stopped by washing in
citrate buffer and 0.1 M PB, pH 7.4. Subsequent to postfixation in 2%
osmium tetroxide in 0.1 M PB for 40min, the sections were dehydrated in
graded ethanols and infiltratedwith a propylene oxide/Epon 812mixture
(1:1 then 1:3, respectively). Themixture was replaced by 100% Epon 812
and incubated overnight at 4°C followed by placement between two
sheets of acetate at 60°C for 24 h for flat embedding. Ultrathin sections
(80 nm thick) were collected from the ARC (between the retrochiasmatic
area anteriorly and the mammillary bodies posteriorly), counterstained
with uranyl acetate/lead nitrate, and examinedwith a JEOL 100CX trans-
mission electron microscope.
Data analysis. For analysis of the subcellular distribution of silver-
enhanced gold particles, sections (	100 sections in total, collected from
two blocks per animal) were randomly scanned, and each field exhibiting
gold particles was photographed at an original magnification of 5000–
10,000. Additional sections from tissue incubated in the absence of
primary antibodies were also analyzed in each animal to assess nonspe-
cific background labeling. Negatives from electron microscopic pho-
tomicrographs were scanned at 1200 dpi resolution on an AGFA Du-
oscan T1200 scanner (AGFA Canada). The digitized negatives were
processed using Adobe Photoshop 6.0 (Adobe Systems) and MS Power-
point software (Microsoft) on an IBM-compatible computer. Gold par-
ticles were then counted and classified according to the type of tissue
component, perikarya, terminals, or dendrites, with which they were
associated. Dendrite- and cell body-associated grains were further clas-
sified as intracellular or membrane associated. Plasma membrane-
associated grains overlying or located immediately adjacent to a postsyn-
aptic density or a contact with a presynaptic active zone were scored as
“subsynaptic” or “perisynaptic,” respectively, and regarded as synapse
associated. All morphometry was done using Neurolucida, release 7.0
(MicroBrightField).
Postsynaptic specializations in sst1-positive dendritic profiles were
identified as open contours using different identifiers for asymmetric and
symmetric contacts (respectively). Their lengths as well as the circumfer-
ence of the dendritic profiles were also determined using Neurolucida
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Figure 1. Ultradian rhythmicity of GH secretion. Individual representative plasma GH profiles of two pairs of animals killed at
11:00 A.M. (A) or 1:00 P.M. (B), i.e., after a predicted trough or peak period in plasma GH concentration (arrows).
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(MicroBrightField). Calculations were performed using MS Excel 2003
and GraphPad Prism 4.03 (GraphPad Software). All data were normal-
ized and expressed as mean percentages  SE. Statistical analyses were
performed on both absolute and normalized data, which yielded the
same levels of statistical significance. p 0.05 was considered significant.
Electronmicroscopic experiments were analyzed using the nonparamet-
ric Kruskal–Wallis test followed by group comparisons using either the
Mann–Whitney U test or Dunn’s multiple-comparison tests. In those
studies comparing two groups only, the nonparametric Mann–Whitney
U test was used. With respect to GHmeasurements, Student’s two-tailed t
test was used for statistical comparison between experimental groups. The
integrated area under the GH response curve (AUC) was calculated by the
linear trapezoidal method. Results were expressed as the mean SE.
Results
GH secretion profiles
Figure 1, A and B, illustrates the spontaneous GH secretory pro-
files of two representative pairs of animals, killed either at the end
of a GH trough period (Fig. 1A) or following a GH secretory
episode (Fig. 1B). The typical pulsatile pattern of GH release was
observed with high-amplitude GH peaks occurring at the pre-
dicted time. Themean AUC for the 2 h period before the animals
were killed was more than threefold lower in animals killed fol-
lowing aGH trough period than that observed in animals killed at
the end of a GH secretory episode (mean 2 h GH AUC: 45.0 
25.8 vs 142.5  4.3 ng/ml  h; p  0.02). Thus, both the GH
profiles (Fig. 1) and the corresponding AUC data demonstrate
that animals killed at 11:00 A.M. were exposed to a prolonged
period of low plasma GH levels before they were killed, whereas
animals killed at 1:00 P.M. had completed a full GH secretory
episode and were exposed to plasma GH levels as high as 200
ng/ml before they were killed.
Immunohistochemistry for sst1 , VGluT2, and VGAT in
the ARC
To establish the pattern of distribution of sst1 immunoreactivity
in the ARC, we incubated frontal sections of rat mediobasal hy-
pothalamus with our N-terminal sst1 antiserum, which has been
extensively characterized (Stroh et al., 2006). In agreement
with previous findings (Stroh et al., 2006),
numerous sst1-immunopositive neuronal
cell bodies were distributed throughout
the ARC (supplemental Fig. 1A, available
at www.jneurosci.org as supplementalma-
terial). These sst1-positive neurons were
particularly densely concentrated in the
ventral aspect of the nucleus, where
GHRH-producing cells have been re-
ported to be localized (Sasaki et al., 1994;
Romero andPhelps, 1997; Tannenbaumet
al., 1998). In addition, faint labeling of
elongated and punctate structures, remi-
niscent of dendrites and terminals or cut
dendritic profiles, was evident in between
the cell bodies (supplemental Fig. 1A,
available at www.jneurosci.org as supple-
mental material).
The ARC is a highly regulated hypotha-
lamic area and receives dense synaptic in-
put. To elucidate the neurochemical iden-
tity of synaptic terminals in this region, we
incubated parallel sections of mediobasal
hypothalamus with antibodies recogniz-
ing VGluT2 and VGAT, respectively. In
agreement with previous reports
(Hrabovszky et al., 2005; Kiss et al., 2006), single labeling for
VGluT2 revealed dense VGluT2-positive punctate staining, likely
excitatory terminals, throughout the ARC (supplemental Fig. 1B,
available at www.jneurosci.org as supplemental material). Incu-
bation of parallel sections with an antibody recognizing VGAT
demonstrated that the ARC also exhibits densely packed VGAT-
immunopositive punctate structures, presumably inhibitory
synaptic terminals (supplemental Fig. 1C, available at www.
jneurosci.org as supplemental material). In fact, VGAT im-
munoreactivity was so dense that the ARC stood out strikingly
from the surrounding hypothalamus (supplemental Fig. 1C,
available at www.jneurosci.org as supplemental material). High-
magnificationmicrographs show that both vesicular neurotrans-
mitter transporter antibodies labeled bead-like structures that
tended to encircle what appeared to be neuronal cell bodies in
the ARC (supplemental Fig. 1B,C, insets, available at www.
jneurosci.org as supplemental material).
Double immunofluorescence for sst1 and either VGluT2 or
VGAT analyzed by confocal microscopy revealed that sst1-
positive neurons in the ventral ARC appear to be contacted both
by numerous VGAT-positive, putatively GABAergic (Fig. 2A–C)
and abundant VGluT2-positive, likely glutamatergic, terminals
(Fig. 2D–F).
Immunofluorescence colocalization of sst1 and GHRHwithin
ARC neurons
To show that sst1-positive neurons are not only located in the area
of the ARC corresponding to the location of GHRH neurons but
are also immunoreactive for the neurohormone we double
stained sections of mediobasal hypothalamus using our rabbit
sst1 antiserum and a sheep antiserum against rat GHRH [GRF(1–
29)NH2], also previously developed and characterized by us
(Tannenbaum et al., 1990). In keeping with our immunohisto-
chemical results, we found sst1-positive neurons throughout the
ventral ARC (Fig. 3A), although the labeling was less intense than
immunoperoxidase. In addition, moderate numbers of GHRH-
immunopositive neurons were distributed in the same area as the
sst1
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Figure 2. Coronal sections through the rat arcuate nucleus double immunostained for sst1 and VGAT (A–C) or VGluT2 (D–F ).
Note the dense innervation of arcuate sst1-positive neurons bothwith VGAT-positive terminals (C, arrows) and terminals positive
for VGluT2 (F, arrows). Scale bar: (in F ) A–C, 15m; D–F, 10m.
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sst1-positive neurons (Fig. 3B). Almost all
of the sst1-positive cells were also stained
for GHRH (Fig. 3A,C, arrowheads). Con-
versely, a subpopulation of GHRH-
positive cells did not colocalize the sst1
protein (Fig. 3B,C, arrows). We used un-
biased stereological sampling (Optical
Fractionator probe) to provide a quantita-
tive estimate of the sst1- and GHRH-
positive neuronal populations as well as
the number of sst1/GHRH dually positive
cells in the rat ARC. In three individual
brains, we foundmean numbers SEMof
10,322  2152 sst1-positive, 12,183 
2580 GHRH-positive, and 9007  2413
sst1/GHRH double-positive neurons in
theARC. These results indicate that	87%
ofARCneurons expressing the sst1 protein
also synthesize GHRH and 74% of GHRH
neurons have the sst1 receptor.
Subcellular dynamics in the arcuate
nucleus in parallel with pulsatile
GH secretion
As in previous studies in the ARC (Stroh et
al., 2006), silver-enhanced gold grains in-
dicative of immunoreactive sst1 receptors
were concentrated over profiles of neuro-
nal cell bodies and dendrites in the ventral
ARC (Fig. 4A). In total, 1092 silver/gold
particles were analyzed (after peak: 837; af-
ter trough: 255). Whereas many of these
silver particles were located at the plasma
membrane (Fig. 4A, arrows), the majority
was associatedwith intracellular structures
such as Golgi stacks (Fig. 4A, arrowheads)
and numerous vesicular organelles. Quan-
titative analysis revealed that 80% of the
silver/gold particles were intracellular and
20% located at the plasmamembrane (Fig.
4B) (n  3 independent experiments).
This ratiowas extremely stable throughout
the GH secretion cycle; it was completely
independent of whether the animal had
been killed at the end of a GH trough or a
GH peak (Fig. 4B).
A strikingly large proportion of the
plasma membrane-associated sst1 receptors
were located next to or right on the postsyn-
aptic zone of both symmetric and asymmet-
ric terminals abutting the sst1-positive den-
dritic profiles (Fig. 5A–D). In contrast to the
general subcellular distribution of sst1, this
association with synaptic specializations
proved to be highly dynamic in parallel with
the ultradian rhythmofGH secretion. Thus,
29.9% of plasma membrane-associated sst1
receptors were located at postsynaptic spe-
cializations (total: 50 of 167) following GH
secretion peak periods, whereas 42.0% (total: 21 of 50) were located
at such sites at the end of GH troughs ( p 0.05). Independently of
the animals’ GH status sst1 showed a preference for symmetric over
asymmetric contacts (82%vs 18%after peak comparedwith 76%vs
24% after trough; p  0.005) (Fig. 6). Whereas sst1 receptors at
symmetric synapses were all perisynaptic following a trough in GH
secretion, 15% were located subsynaptically subsequent to a GH
secretoryperiod ( p0.05) (Figs. 5A,B, 6). Inaddition,perisynaptic
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Figure 3. Coronal sections through the ratmediobasal hypothalamus at the level of the ARC. Sections were double stained for
sst1 (A) andGHRH (B). Note thatnumerousARCGHRHneurons are immunopositive for sst1 (A,C; arrowheads). sst1-negativeGHRH
cells are indicated by arrows in B and the merged image (C). The images represent a confocal z-stack of 12 optical sections, each
4.7m thick, whichwere projected onto one plane and corrected for brightness and contrast using Photoshop CS2. Scale bar, 30
m.D, Unbiased stereological estimates of the numbers of sst1- andGHRH-immunopositive neurons andneurons double labeled
for both the receptor and the peptide (“Double”) in the rat ARC. Stereological data represent means SEM from three rats.
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Figure 4. Subcellular distributionof sst1 in thearcuatenucleus.A, Electronmicrographof an sst1-positivedendritic profile.While two
silver particles, representing immunoreactive sst1 receptors, are locatedat theplasmamembrane (arrows), thebulk of immunoreactivity
is found intracellularly (arrowheads), associated with vesicular organelles and, notably, the Golgi apparatus (G). Scale bar, 750 nm. B,
Quantificationofsubcellular sst1distribution inanimalskilledfollowingaGHpeak(PostGHPeak)or trough(PostGHTrough), respectively.
Data are expressed as percentages of the total number of receptors within each group. Eighty percent of immunoreactive sst1 are intra-
cellular and 20% located at the plasmamembrane regardless of GH status. Data represent means SEM; n 3 independent experi-
ments. Absolute numbers of immunoreactive receptors are indicatedwithin the columns.
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membrane invaginations containing immunoreactive sst1 were ob-
served at some symmetric synapses (Fig. 5B). In contrast, subsynap-
tic sst1 receptors were found at asymmetric synapses following both
GH trough and peak periods, but their percentage never exceeded
5% (Fig. 6).
In addition to the synaptic localization
of sst1 receptors in ARC neurons, synaptic
connectivity of the nucleus itself also ex-
hibited ultradian dynamics. Thus, the pro-
portions of asymmetric and symmetric
synaptic profiles (as measured by the
length of presynaptic and postsynaptic
specializations along the dendritic mem-
brane) contacting the circumference of
sst1-positive profiles, indicative of excita-
tory and inhibitory innervation, respec-
tively (Uchizono, 1965; Peters et al., 1991),
were approximately equal following GH
troughs. However, at the end of a GH se-
cretory episode, 70% of the contacts were
now symmetric, i.e., inhibitory, whereas
the percentage of asymmetric synapses
dropped to 30% ( p 0.02) (Fig. 7).
Discussion
In the present study, we demonstrate that
somatodendritic sst1 SRIF receptors are
present in a subset of GHRH-
immunopositive neurons of the rat ARC
and exhibit an association with postsynap-
tic specializations that fluctuates in paral-
lel with the ultradian cycle of GH secre-
tion, providing a possible explanation for
the ultradian oscillations of SRIF binding
in the ARC previously reported (Tannen-
baum et al., 1993). We also show that the
relative abundance of excitatory and in-
hibitory inputs to sst1-positive neurons in
the ARC similarly varies in an ultradian
manner dependent on the GH secretion cycle.
Early immunohistochemical studies in the rat found the sst1
receptor protein restricted to the anterior periventricular nucleus
and themedian eminence (Helboe et al., 1998). Subsequent stud-
ies using different antibodies (Hervieu and Emson, 1998; Stroh et
al., 2006; Kumar, 2007) revealed amuchwider distribution of the
receptor in the rat brain, including the ARC. The distribution of
sst1 protein demonstrated here conformed to these reports and
also to sst1 mRNA distribution in the ARC (Pe´rez et al., 1994;
Sen˜arís et al., 1994; Beaudet et al., 1995).
We also showed through unbiased stereological estimation
that almost 90% of sst1-immunoreactive neurons labeled in the
ventral ARC costained for GHRH, as revealed using a previously
characterized GHRH antiserum (Tannenbaum et al., 1990).
Conversely, 75% of immunolabeled GHRH neurons were sst1
positive, confirming thenotion that sst1maybe amajorplayer in the
mediation of SRIF effects in the central regulation of GH secretion
(Tannenbaum and Epelbaum, 1999; Lanneau et al., 2000).
Dual immunostaining using either antibodies recognizing
VGluT2 (Fremeau et al., 2001) or antibodies against VGAT
(McIntire et al., 1997; Chaudhry et al., 1998) revealed that sst1-
positive ARC neurons were in close proximity with numerous
VGluT2- andVGAT-positive terminals.While these findings donot
constitute proof of the presence of synaptic input, due to the resolu-
tion limit of light microscopy, they suggest a dense innervation of
these ARC neurons by both excitatory and inhibitory terminals.
In keeping with the results of our own previous studies (Stroh
et al., 2006), the present electron microscopic observations show
that, in neurons of the ARC, immunoreactive sst1 receptors are
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Figure 5. Temporal variation in the localization of sst1 at synaptic active zones in relation to the GH cycle. A–D, High-
magnification electron micrographs of the arcuate nucleus neuropil immunostained for sst1 show that a high proportion of sst1
receptors at the plasmamembrane are located at or next to synaptic contacts (arrows). A, B, Examples of plasmamembrane sst1
receptors at the subsynapticmembrane of symmetric synapses (arrows) in ARC of animals killed at the end of a GH secretion peak.
B, In some instances, sst1-positive tubular membrane invaginations were observed in the perisynaptic zone of these synapses
(arrowhead). C,D, Perisynaptic sst1 receptors located lateral to the postsynaptic densities of asymmetric synapses. Scale bars: (in
B) A, 180 nm; B, 100 nm; (in D) C, D, 250 nm.
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Figure 6. Association of sst1 with symmetric as compared with asymmetric synapses. Peri-
synaptic and synaptic sst1 receptors were classified as being associated with a symmetric or an
asymmetric synaptic contact following peak (Post Peak) or trough (Post Trough) periods in the
GH secretion cycle. Data represent means SEM of data from three independent experiments
( p 0.005). The data are expressed as percentages of all receptors located in perisynaptic or
subsynaptic positions following a period of high GH secretion (Post Peak) or a GH trough (Post
Trough), respectively. A significant association of sst1 receptors with symmetric synapses was
observed (*p 0.05 vs all other groups).
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predominantly localized intracellularly, in associationwith vesic-
ular organelles (80% intracellular, 20% on the plasma mem-
brane). Such a pattern of distribution has been described for
several GPCRs. For instance, the closely related sst2A receptor sub-
type ismainly intracellular in brain areas receiving a dense SRIFergic
innervation but more heavily surface bound in regions receiving a
sparse SRIF innervation (Dournaud et al., 1998). It is therefore con-
ceivable that, as postulated for sst2, the predominantly intracellular
localization of sst1 observedheremaybe due to receptor internaliza-
tion in response to the endogenous agonist since theARCcontains a
particularly dense network of SRIF-positive fibers.
The ratio of membrane-associated over intracellular sst1 re-
ceptors was the same at both times of the ultradian GH cycle
examined and conformed to that previously reported in animals
of undetermined GH status (Stroh et al., 2006). However, in the
present study, a redistribution of cell-surface sst1 receptors was
observed between GH peak and trough periods. Whereas 30% of
the plasma membrane-associated sst1 receptors occupied peri-
synaptic or subsynaptic positions following a period of high GH
secretion, a significantly higher proportion (42%) was observed
at such sites at the end of a GH trough period (low GH release).
Although a similar perisynaptic localization has been reported for
the metabotropic glutamate receptors mGluR1 and mGluR5
(Luja´n et al., 1997), this is the first report of an ultradian variation
in a GPCR synaptic localization.
In the ARC, the bulk of synaptic sst1 receptors were observed
at symmetric (i.e., inhibitory) synapses following GH peaks. The
occasional observation of sst1-positive membrane invaginations
in perisynaptic position with respect to these sst1-labeled sym-
metric synapses at the end of a GH peak may indicate increased
sst1 internalization, subsequent to increased SRIF release, at these
sites. These results suggest that sst1 may play an important role in
regulating the inhibition of GH release by SRIF.
Hypothalamic SRIF release into both the hypophyseal portal
circulation and within the ARC is cyclical and exhibits a 3–4 h
pattern of release (Plotsky and Vale, 1985; Wagner et al., 1998).
At the pituitary level, SRIF interacts with GHRH to regulate so-
matotropes whereas in the ARC it acts to inhibit GHRH-
producing neurons. There is also evidence that within the ARC,
GH can influence the expression of sst1 (but not sst2) receptors,
presumably through SRIF release (Guo et al., 1996). It is therefore
tempting to speculate that the cyclical release of SRIF in the ARC
might regulate the subcellular localization of sst1 receptors in
GHRH-producing neurons. Such a mechanism would be in
agreement with in vitro studies showing that sst1 may be targeted
from intracellular stores to the plasmamembrane following SRIF
stimulation in certain cell types (Ramírez et al., 2005).
In addition to plasticity in the distribution of cell-surface sst1
receptors, we observed structural plasticity within the ARCunder
the influence of the endogenous GH cycle. sst1-immunoreactive
dendritic profiles received both numerous asymmetric (Gray
type 1) synapses with prominent postsynaptic densities and sym-
metric (Gray type 2) synapses. However, whereas approximately
equal proportions of symmetric and asymmetric synaptic inputs
were observed following GH trough periods, this ratio is shifted
to 70:30 in favor of symmetric, i.e., inhibitory, inputs after pro-
longed exposure to high circulating GH, suggesting that a rewir-
ing of the synaptic connectivity has taken place during the GH
peak period. This finding is consistent with reports of various
forms of synaptic reorganization in the hypothalamus in re-
sponse to exogenous signals and endogenous rhythms such as
changes in water balance (Miyata et al., 1994; Stern and Arm-
strong, 1998) or in circulating levels of estradiol (Garcia-Segura
et al., 1986; Zsarnovszky et al., 2001; Parducz et al., 2003). Simi-
larly, synaptic plasticity together with changes in the molecular
machinerymodulating synaptic efficacymay play a key role in the
regulation of GH secretion at the level of the hypothalamus.
The present results, together with our previous work (Tan-
nenbaum et al., 1993;Wagner et al., 1998), suggest that at the end
of a GH peak there is an increase in inhibitory synaptic input
concomitant with increased concentrations of extracellular SRIF,
which are instrumental in terminating the burst of GH secretion
and inducing the ensuing trough in the GH cycle. The increase in
extracellular SRIF induces a lateral mobilization of perisynaptic
sst1 receptors to the subsynaptic membrane as well as an in-
creased internalization of sst1. As compensation, intracellular sst1
receptors are targeted to extrasynaptic plasma membrane sites
and are eventually laterally mobilized to replenish the pool of
perisynaptic/subsynaptic receptors during the following GH
trough. Such amechanismwould explain our earlier observation
that SRIF binding to the ARC is paradoxically highest during GH
peaks (Tannenbaum et al., 1993) as external radioactive ligand
has conceivably greater access to nonsynaptic receptors than to
spatially restricted synaptic sites.
In conclusion, the results reported here suggest that ARC neu-
rons actively regulate the postsynaptic localization of the sst1 recep-
tor in conjunction with the ultradian rhythm of the GH secretion
cycle. They also indicate that the synaptic connectivity of sst1-
positive ARC neurons undergoes pronounced remodeling in paral-
lel with the GH rhythm. Differential modulation of synaptic trans-
mission mediated by sst1 and synaptic remodeling may thus be
important mechanisms by which sst1 mediates cyclical SRIFergic
effects on ARC GHRH neurons in generating the ultradian rhyth-
micity of GH secretion.
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